X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2360) 2360
Publication (210) 210
Book Review (62) 62
Book Chapter (26) 26
Magazine Article (6) 6
Dissertation (4) 4
Book / eBook (3) 3
Conference Proceeding (3) 3
Data Set (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1412) 1412
index medicus (1314) 1314
osteonecrosis (1275) 1275
male (871) 871
female (866) 866
necrosis (643) 643
bones (587) 587
animals (566) 566
middle aged (522) 522
osteoporosis (494) 494
adult (425) 425
orthopedics (422) 422
aged (406) 406
bisphosphonates (404) 404
endocrinology & metabolism (389) 389
dentistry (363) 363
avascular necrosis (359) 359
bone (355) 355
dentistry, oral surgery & medicine (353) 353
osteonecrosis - chemically induced (352) 352
diphosphonates - adverse effects (345) 345
risk factors (345) 345
surgery (323) 323
zoledronic acid (304) 304
bone density conservation agents - adverse effects (288) 288
jaw (286) 286
medicine & public health (265) 265
risk-factors (264) 264
femoral-head (262) 262
analysis (249) 249
rheumatology (221) 221
rats (215) 215
therapy (213) 213
osteonecrosis - pathology (210) 210
care and treatment (205) 205
alendronate (197) 197
bisphosphonate (196) 196
cancer (195) 195
medicine, research & experimental (181) 181
bone density conservation agents - therapeutic use (180) 180
prevention (180) 180
aged, 80 and over (179) 179
diphosphonates - therapeutic use (174) 174
apoptosis (172) 172
bisphosphonate-related osteonecrosis (172) 172
disease models, animal (172) 172
health aspects (165) 165
phosphonates (164) 164
jaw diseases - chemically induced (161) 161
rabbits (160) 160
fractures (157) 157
research (157) 157
osteonecrosis - etiology (156) 156
expression (150) 150
osteonecrosis of the jaw (149) 149
oncology (145) 145
treatment outcome (145) 145
cells (140) 140
femur (140) 140
bone density conservation agents - administration & dosage (139) 139
diphosphonates - administration & dosage (137) 137
disease (136) 136
mice (136) 136
magnetic resonance imaging (133) 133
hip (132) 132
in-vitro (131) 131
pathogenesis (131) 131
bone marrow (128) 128
stem cells (128) 128
adolescent (127) 127
angiogenesis (125) 125
diphosphonates (122) 122
endocrinology (121) 121
differentiation (120) 120
corticosteroids (117) 117
retrospective studies (117) 117
osteoblasts (114) 114
gene expression (113) 113
osteoporosis - drug therapy (113) 113
diphosphonates - pharmacology (112) 112
medicine (112) 112
risk (112) 112
femur head necrosis - pathology (111) 111
diagnosis (110) 110
abridged index medicus (107) 107
biocompatibility (106) 106
cells, cultured (106) 106
cell biology (105) 105
time factors (105) 105
osteogenesis (104) 104
article (103) 103
drug therapy (103) 103
femur head - pathology (101) 101
postmenopausal women (101) 101
osteonecrosis - metabolism (100) 100
bone density (99) 99
medical research (99) 99
patients (99) 99
multiple-myeloma (98) 98
denosumab (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2308) 2308
German (22) 22
Spanish (12) 12
French (11) 11
Italian (7) 7
Japanese (7) 7
Chinese (6) 6
Korean (6) 6
Portuguese (6) 6
Czech (2) 2
Polish (2) 2
Croatian (1) 1
Dutch (1) 1
Hungarian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cellular Physiology, ISSN 0021-9541, 07/2013, Volume 228, Issue 7, pp. 1506 - 1515
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 08/2017, Volume 118, Issue 8, pp. 2072 - 2086
ABSTRACT Steroid, also known as glucocorticoid, induced osteonecrosis of the femoral head in young adults, which has been a challenging disorder for the... 
STEROID | Wnt3a/β‐CATENIN | NF‐κB | ST1926 | OSTEONECROSIS | NF-κB | Wnt3a/β-CATENIN | HUMAN OSTEOBLASTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CATENIN | NF-B | FRACTURE RISK | CELL BIOLOGY | BONE LOSS | INDUCED OSTEONECROSIS | Wnt3a | GENE-EXPRESSION | RETINOIC ACID RECEPTOR | TNF-ALPHA | POSTMENOPAUSAL WOMEN | TYPE-2 DIABETES-MELLITUS | FEMORAL-HEAD | Wnt3A Protein - metabolism | Rats, Wistar | Alkaline Phosphatase - metabolism | Male | Methylprednisolone - adverse effects | NF-kappa B - metabolism | Osteonecrosis - metabolism | Osteonecrosis - genetics | Bone Morphogenetic Proteins - metabolism | Osteonecrosis - drug therapy | Bone Resorption - genetics | Osteoprotegerin - genetics | Bone Resorption - metabolism | Bone Resorption - chemically induced | Bone Morphogenetic Proteins - genetics | Adamantane - analogs & derivatives | Adamantane - pharmacology | Alkaline Phosphatase - genetics | Wnt3A Protein - genetics | Signal Transduction | Osteoblasts - drug effects | Gene Expression Regulation | Rats | Cinnamates - pharmacology | Methylprednisolone - analogs & derivatives | Osteoclasts - metabolism | beta Catenin - metabolism | beta Catenin - genetics | Bone Density Conservation Agents - pharmacology | Bone Resorption - prevention & control | Bone Density - drug effects | Animals | NF-kappa B - genetics | Osteonecrosis - chemically induced | Osteoprotegerin - metabolism | Osteoblasts - metabolism | Osteoclasts - drug effects | Osteoporosis | Medical research | Phosphatases | Corticosteroids | RNA | Medicine, Experimental | Inflammation | Retinoids | Femur | Glucocorticoids | Osteonecrosis | Biochemistry | Phosphatase | Density | Incidence | Signal transduction | Computed tomography | Biocompatibility | Bone density | Inhibition | Lipid metabolism | Evaluation | Young adults | Bioavailability | Gene expression | Metabolism | Diseases | Quality of life | Osteoclastogenesis | Bone mass | Adults | Microstructure | Alkaline phosphatase | Surgical implants | Clinical trials | mRNA | Osteoprotegerin | β-catenin | Biomedical materials | Control | Rodents | Bone morphogenetic proteins | Attenuation | Indicators | Hip joint | Collapse | Bone remodelling | Markers | Hip | Lymphocytes B | Bone mineral density | Bone | Differentiation | Osteogenesis | Index Medicus
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 11/2017, Volume 456, Issue C, pp. 16 - 35
Small non-coding RNAs, which are 20–25 nucleotide ribonucleic acids, have emerged as an important transformation in the biological evolution over almost three... 
miRNA | siRNA | Bone metabolism | Targeting therapeutics | DOUBLE-STRANDED-RNA | NITRIC-OXIDE SYNTHASE | MESENCHYMAL STEM-CELLS | INHIBITS OSTEOGENIC DIFFERENTIATION | CELL BIOLOGY | STEROID-ASSOCIATED OSTEONECROSIS | SMALL INTERFERING RNA | HUMAN PROSTATE-CANCER | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | ENDOCRINOLOGY & METABOLISM | NF-KAPPA-B | SIZED CALVARIAL DEFECTS | MicroRNAs - therapeutic use | Bone and Bones - pathology | RNA, Small Interfering - genetics | Bone Neoplasms - therapy | Osteoporosis - therapy | Humans | MicroRNAs - metabolism | Bone Neoplasms - pathology | Core Binding Factor Alpha 1 Subunit - metabolism | Osteoarthritis - therapy | Bone Neoplasms - metabolism | Osteoporosis - metabolism | Bone and Bones - metabolism | Osteoporosis - genetics | Bone Neoplasms - genetics | Osteoarthritis - pathology | Molecular Targeted Therapy - methods | Signal Transduction | Gene Expression Regulation | Activating Transcription Factor 4 - genetics | Osteoarthritis - metabolism | beta Catenin - metabolism | Osteoarthritis - genetics | beta Catenin - genetics | Osteoblasts - pathology | Animals | Activating Transcription Factor 4 - metabolism | Osteoporosis - pathology | RNA, Small Interfering - therapeutic use | Sp7 Transcription Factor - genetics | Sp7 Transcription Factor - metabolism | MicroRNAs - genetics | Osteoblasts - metabolism | Core Binding Factor Alpha 1 Subunit - genetics | RNA, Small Interfering - metabolism | Medical colleges | MicroRNA | Laws, regulations and rules | Therapeutics | Health aspects | Homeopathy | Materia medica and therapeutics
Journal Article
Scientific Reports, ISSN 2045-2322, 03/2017, Volume 7, Issue 1, p. 44618
Through a process called perilacunar remodeling, bone-embedded osteocytes dynamically resorb and replace the surrounding perilacunar bone matrix to maintain... 
APOPTOSIS | SCLEROSTIN | HOMEOSTASIS | MATRIX METALLOPROTEINASE-13 | MULTIDISCIPLINARY SCIENCES | BMP ANTAGONIST | MINERALIZATION | OSTEOBLASTS | MECHANISMS | TREATED MICE | FEMORAL-HEAD | Bone Matrix - metabolism | Osteocytes - drug effects | Prednisolone - adverse effects | RANK Ligand - metabolism | Humans | Male | Osteonecrosis - metabolism | Osteonecrosis - pathology | Bone Remodeling - drug effects | Delayed-Action Preparations - administration & dosage | Osteonecrosis - genetics | Bone Matrix - drug effects | Osteoprotegerin - genetics | Glucocorticoids - adverse effects | Osteocytes - metabolism | Matrix Metalloproteinase 2 - metabolism | Matrix Metalloproteinase 13 - genetics | Transcription Factors - genetics | Matrix Metalloproteinase 14 - metabolism | Bone Matrix - pathology | Matrix Metalloproteinase 13 - metabolism | Gene Expression Regulation - drug effects | RANK Ligand - genetics | Transcription Factors - metabolism | Matrix Metalloproteinase 2 - genetics | Cathepsin K - genetics | Animals | Cathepsin K - metabolism | Tartrate-Resistant Acid Phosphatase - metabolism | Matrix Metalloproteinase 14 - genetics | Osteocytes - pathology | Mice | Osteonecrosis - chemically induced | Osteoprotegerin - metabolism | Tartrate-Resistant Acid Phosphatase - genetics | Glucocorticoids | Bone remodelling | Rodents | Collagen | Homeostasis | Osteocytes | Extracellular matrix | Degeneration | Osteonecrosis | Bone turnover | Bone matrix | Bone (subchondral) | BASIC BIOLOGICAL SCIENCES | 60 APPLIED LIFE SCIENCES
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e34647
Glucocorticoid (GC) induced osteoporosis (GIO) is caused by the long-term use of GC for treatment of autoimmune and inflammatory diseases. The GC related... 
TRABECULAR BONE | APPOSITION RATE | CELLS | OSTEOBLAST DIFFERENTIATION | INDUCED OSTEONECROSIS | MULTIDISCIPLINARY SCIENCES | BEAGLE | DANSHEN | EXPRESSION | MILTIORRHIZA | OSTEOPOROSIS | Neovascularization, Physiologic - drug effects | Gene Expression - drug effects | Adipogenesis - drug effects | Benzofurans - administration & dosage | Male | Adipocytes - drug effects | PPAR gamma - metabolism | Core Binding Factor Alpha 1 Subunit - metabolism | Bone and Bones - drug effects | Intercellular Signaling Peptides and Proteins - metabolism | Bone Morphogenetic Proteins - metabolism | Osteoporosis - metabolism | Bone and Bones - metabolism | Stromal Cells - drug effects | Bone Marrow Cells - drug effects | Cell Differentiation | Bone Morphogenetic Proteins - genetics | PPAR gamma - genetics | Prednisone - administration & dosage | Benzofurans - therapeutic use | Osteoporosis - chemically induced | Prednisone - adverse effects | Osteoporosis - prevention & control | Osteoblasts - drug effects | Osteogenesis - drug effects | Stromal Cells - metabolism | Bone and Bones - blood supply | Intercellular Signaling Peptides and Proteins - genetics | Rats | Rats, Sprague-Dawley | beta Catenin - metabolism | beta Catenin - genetics | Animals | Adipocytes - metabolism | Osteoblasts - metabolism | Bone Marrow Cells - metabolism | Core Binding Factor Alpha 1 Subunit - genetics | Osteoporosis | Corticosteroids | Bones | Prednisone | Cell differentiation | Density | Steroids | Oxidative stress | Transcription factors | Glucocorticoids | Laboratories | Differentiation (biology) | Stimulation | Adipocytes | Inflammatory diseases | β-catenin | Angiogenesis | Bone histomorphometry | Biomedical materials | Bone growth | Ischemia | Rodents | Bone marrow | Biocompatibility | Inhibition | Bone loss | Bone strength | Osteopenia | Adipogenesis | Cbfa-1 protein | Research & development--R&D | Medical treatment | Pharmacology | Gene expression | Medicine | Studies | Herbal medicine | Salvia miltiorrhiza | Osteoblastogenesis | Bone mass | Acids | Stem cells | Dilation | Bone mineral density | In vivo methods and tests | Dkk1 protein | Osteogenesis | Bone (cancellous) | Apoptosis | Herbal medicines | Guanylate cyclase | Osteoblasts | adipogenesis | stromal cells | Bone morphogenetic proteins | Differentiation | Research & development | R&D
Journal Article
Journal Article